Stage III Colon Cancer AJCC v7
Information
- Disease name
- Stage III Colon Cancer AJCC v7
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00576654 | Active, not recruiting | Phase 1 | Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery | December 5, 2007 | June 30, 2023 |
| NCT02381561 | Active, not recruiting | Phase 1 | Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy | February 1, 2016 | March 5, 2025 |
| NCT03365882 | Active, not recruiting | Phase 2 | S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery | November 27, 2017 | November 20, 2024 |
| NCT03317119 | Completed | Phase 1 | Trametinib and Trifluridine and Tipiracil Hydrochloride in Treating Patients With Colon or Rectal Cancer That is Advanced, Metastatic, or Cannot Be Removed by Surgery | April 11, 2018 | July 14, 2023 |
| NCT03407716 | Completed | Early Phase 1 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | March 1, 2019 | February 22, 2021 |